GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 343 filers reported holding GLOBUS MED INC in Q3 2020. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,532,000 | +31.6% | 74,027 | +17.3% | 0.75% | -7.3% |
| Q1 2020 | $2,684,000 | -27.8% | 63,110 | -0.1% | 0.81% | +6.0% |
| Q4 2019 | $3,718,000 | +16.2% | 63,146 | +0.9% | 0.76% | -10.2% |
| Q3 2019 | $3,200,000 | +19.7% | 62,589 | -1.0% | 0.85% | +24.6% |
| Q2 2019 | $2,673,000 | -48.1% | 63,193 | -39.4% | 0.68% | -52.8% |
| Q1 2019 | $5,155,000 | +32.0% | 104,323 | +15.7% | 1.45% | +12.9% |
| Q4 2018 | $3,904,000 | -27.9% | 90,199 | -5.4% | 1.28% | -17.8% |
| Q3 2018 | $5,414,000 | +33.9% | 95,381 | +19.0% | 1.56% | +8.6% |
| Q2 2018 | $4,043,000 | +108.1% | 80,120 | +105.4% | 1.44% | +15.2% |
| Q1 2018 | $1,943,000 | +35.9% | 39,008 | -38.4% | 1.25% | +25.2% |
| Q3 2016 | $1,430,000 | +4.4% | 63,360 | +10.2% | 1.00% | -12.0% |
| Q2 2016 | $1,370,000 | +134.2% | 57,470 | +133.3% | 1.13% | -8.0% |
| Q1 2016 | $585,000 | – | 24,630 | – | 1.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sterling Investment Advisors, Ltd. | 197,873 | $11,109,000 | 3.82% |
| Pembroke Management, LTD | 600,148 | $33,692,000 | 3.48% |
| Godshalk Welsh Capital Management, Inc. | 73,101 | $4,104,000 | 2.95% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 688,000 | $38,624,000 | 2.62% |
| XXEC, Inc. | 50,625 | $2,842,000 | 2.26% |
| Van Berkom & Associates Inc. | 885,922 | $49,736,000 | 2.08% |
| GENEVA CAPITAL MANAGEMENT LLC | 1,351,998 | $75,901,000 | 1.75% |
| RTW INVESTMENTS, LP | 1,121,527 | $62,963,000 | 1.63% |
| Global Alpha Capital Management Ltd. | 257,131 | $14,435,000 | 1.56% |
| Ophir Asset Management Pty Ltd | 258,889 | $6,622,381,000 | 1.36% |